Characterization, Intestinal Absorption and Pharmacokinetics of Long-Circulating Nanoparticles Loaded with Panaxnotoginseng saponins

Article Preview

Abstract:

The aim of the present study was to increase bioavailability after oral administration. In this study, Panaxnotoginseng saponins (PNS) was entrapped within the long-circulating nanoparticles (LCNs) by the multiple emulsion method. The PNS-LCNs were characterized in terms of size, zeta potential, morphology, thermal properties, drug entrapment efficiency (EE), and in vitro release of the PNS. In addition, the intestinal absorption of PNS-LCNs in vitro was investigated. The pharmacokinetics of PNS-LCNs following oral administration was determined over 72 h in male rats. It was found that the mean particle size and zeta potential of the PNS-LCNs were 147±4.5nm and −44.7±1.5mV, respectively, and the entrapment efficiency (EE) was 53.93%±0.69%. differential scanning calorimetry (DSC) indicated that PNS has different states in PNS-LCNs and original PNS. The release pattern of the PNS-LCNs followed the Weibull model. The release parameters (T50, TD) were observed to be higher for PNS-LCNs compared with original PNS (p< 0.01) in vitro release. The intestinal absorption study indicated that the intestinal permeability coefficient (Papp) of PNS-LCNs was higher than original PNS’s. The pharmacokinetics of PNS-LCNs was studied after oral administration to male rats, PNS-LCNs provided greater area under the concentration-time curve (AUC), higher plasma concentration (Cmax), longer mean residence time (MRT) and median time to maximum drug concentration (Tmax). LCNs could be used for improving permeability and increased bioavailability after oral administration of PNS.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

227-232

Citation:

Online since:

February 2013

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] X.X. Zhu, Y.W. Mao, R.X. He, et al. Chin. J. Biochem. Pharm. Vol. 19 (1998), p.28.

Google Scholar

[2] A.F.G. Cicero, E. Bandieri, R Arletti. J. Ethnopharm. Vol. 73 (2000), p.387.

Google Scholar

[3] T. Odani, H. Tanizawa, Y. Takino. Chem Parm Bull. Vol . 31 (1983), p.292.

Google Scholar

[4] M. Han, L. M. Han, Q. S. Wang, et al. Acta Pharm. sinica Vol. 41(2006), p.498.

Google Scholar

[5] Y. Wang, T. H. Liu, W. Wang, et a1. Acta Parm sinica Acta Pharm. sinica Vol. 35(2000), p.284.

Google Scholar

[6] M. Michael, B. Corey, B. Ron, et al. Pharm Res Vol. 24(2011), p.427.

Google Scholar

[7] W. H. Ren, J. Chang, C. H. Yan, et al. J. Mater. Sci.: Mater. in Medic. Vol . 21(2010), p.2673.

Google Scholar

[8] G. W. Zhao, X. L. Chen, Z. G. Liao, et al. Chin Hosp Pharm J. Vol. 31(2011), p.1329.

Google Scholar

[9] D Lemoine, V. J. Preat. Control Release. Vol. 54(1998), p.15.

Google Scholar

[10] A.S. Al-Khalifa, K.L. Simpson. Comp. Biochem. Physiol Vol. 91(1988), p.563.

Google Scholar

[11] T. H. Wilson, G. Wiseman.J. Physiol. Vol. 123(1954), p.116.

Google Scholar

[12] A. Dahiqvist. Anal Biochem Vol. 22 (1968), p.99.

Google Scholar

[13] H. Komatsu, A. Kitajima, S. Okada. Chem Pharm Bull. Vol. 43(1995), p.1412.

Google Scholar